首页> Journal of Crohn's & colitis> Switching to subcutaneous administration may offer more profound remission compared to intensified intravenous therapy in patients with inflammatory bowel disease and partial response following induction with intravenous vedolizumab: the PRIVEDO study.

Switching to subcutaneous administration may offer more profound remission compared to intensified intravenous therapy in patients with inflammatory bowel disease and partial response following induction with intravenous vedolizumab: the PRIVEDO study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Fabio Salvatore,Macaluso

第一单位： Inflammatory Bowel Disease Unit, "Villa Sofia-Cervello" Hospital, Palermo, Italy.

作者： Fabio Salvatore,Macaluso ^[1] ; Walter,Fries ^[2] ; Anna,Viola ^[2] ; Maria,Cappello ^[3] ; Piera,Melatti ^[3] ; Filippo,Mocciaro ^[4] ; Barbara,Scrivo ^[4] ; Simona,Di Caro ^[5] ; Stefano,Muscarella ^[5] ; Concetta,Ferracane ^[6] ; Emiliano,Giangreco ^[7] ; Maria Giovanna,Minissale ^[8] ; Mauro,Grova ^[9] ; Raffaele,Li Voti ^[1] ; Giuseppe,Mistretta ^[1] ; Sara,Renna ^[1] ; Angelo,Casà ^[1] ; Samuele,Armetta ^[1] ; Simona,Morello ^[1] ; Ambrogio,Orlando ^[1] ; Sicilian Network for Inflammatory Bowel Disease

作者单位： Inflammatory Bowel Disease Unit, "Villa Sofia-Cervello" Hospital, Palermo, Italy. ^[1] Inflammatory Bowel Disease Unit, "G. Martino" Hospital, Messina, Italy. ^[2] Gastroenterology & Hepatology Section, PROMISE, University of Palermo, Palermo, Italy. ^[3] Gastroenterology and Endoscopy Unit, "ARNAS Civico-Di Cristina-Benfratelli" Hospital, Palermo, Italy. ^[4] Gastroenterology and Endoscopy Unit, "S. Antonio Abate" Hospital, Trapani, Italy. ^[5] Gastroenterology Unit, "Vittorio Emanuele" Hospital, Catania, Italy. ^[6] Gastroenterology Unit, "Guzzardi" Hospital, Vittoria, Italy. ^[7] Gastroenterology and Endoscopy Unit, "Buccheri La Ferla Fatebenefratelli" Hospital, Palermo, Italy. ^[8] Endoscopy Unit, "Villa Sofia-Cervello" Hospital, Palermo, Italy. ^[9]

关键词 Crohn’s disease biologics precision medicine ulcerative colitis